Skip to content

The Randomized Controlled Clinical Trial for Validity and Safety of Home Based Telerehabilitation in Ischemic Cerebral Stroke Disability Rehabilitation

The application for telemedicine in post-stroke rehabilitation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005233
Enrollment
Unknown
Registered
2014-09-16
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic cerebral stroke

Interventions

Telerehabilitation group:Exercise rehabilitation and myoelectric biofeedbac
conventional rehabilitation group:Exercise rehabilitation and myoelectric biofeedbac

Sponsors

the Fifth Peoples' Hospital of Shanghai, Fudan Uniersity
Lead Sponsor

Eligibility

Age
35 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. To be aged between 35 to 85 years old, male or female; 2. First diagnosed as cerebral infarction according to 2010 Chinese guidelines for management of patients with acute ischemic stroke after treatment and in a stable condition or with the history of ischemic stroke without neurological disability; 3. Duty focus confirmed by head CT or MRI; 4. Onset of disease from 14 days to 3 months, with neurological disability; 5. NIHSS score assessment from 2 to 20 before recruitment, mRS index from 1 to 4 before recruitment without formal rehabilitation treatment; 6. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. GSC score was under 15, confirmed dementia by MMSE assessment, with mental disorders and can not cooperate with examination and treatment; 2. with neurological disability was not induced by cerebral infarction or with neurological disability induced by historical cerebral infarction; 3. Combined with severe primary disease of heart, liver, kidney and hematological system; 4. with cognitive disorder, history of psychosis, substance abuse,history of alcoholism; 5. with skin infections and burst in antebrachium and crus; 6. Combined with hemorrhagic and skin ulcers tendency; 7. with metal implant such as cardiac Pacemaker, metal stent, steel plate; 8. with gestation or lactation period or fertility plan; 9. Combined with malignant tumor or severe progressive disease in other system; 10 Have been recruited by other clinical trial in recent 3 months; 11. Unable to complete the basic course of treatment,with poor treatment re adherence or unable to follow-up; 12. Other conditions that unable to continue the trial confirmed by assessors.

Design outcomes

Primary

MeasureTime frame
Barthel index assessmen;

Secondary

MeasureTime frame
NIHSS assessment;Modified Rankin Scale score;Water drinking test assessment;Surface electromyograph;

Countries

China

Contacts

Public ContactChuancheng Ren
rccnsf@sina.com+86 021 24289220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026